Cysticidal therapy: Impact on seizure control in epilepsy associated with neurocysticercosis

Arquivos de Neuro-Psiquiatria

Volumn 58, Issue 4, 2000, Pages 1014-1020

  Dos Santos, Isabel Cristina ^b   Kobayashi, Eliane ^b   Cardoso, Tânia Marchiori ^b   Guerreiro, Carlos Alberto Mantovani ^b   Cendes, Fernando ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b NONE

Author keywords

Albendazol; Computerized tomography; EEG; Epilepsy; Neurocysticercosis; Partial seizures; Praziquantel

Indexed keywords

ALBENDAZOLE; PRAZIQUANTEL;

ADULT; ARTICLE; CELL VIABILITY; CLINICAL ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CYST; DRUG EFFICACY; ELECTROENCEPHALOGRAPHY; EPILEPSY; FEMALE; HUMAN; MALE; NEUROCYSTICERCOSIS; PLEOCYTOSIS;

EID: 0343390412     PISSN: 0004282X     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0004-282x2000000600006     Document Type: Article

References (32)

1. Carpio A, Escobar A, Hauser WA. Cysticercosis and epilepsy: a critical review. Epilepsia 1998;39:1025-1040.
2. Pal DK, Carpio A, Sander JW. Neurocysticercosis and epilepsy in developing countries. J Neurol Neurosurg Psychiatry 2000;68:137-143.
3. Del Brutto OH. Prognostic factors for seizure recurrence after withdrawal of antiepileptic drugs in patients with neurocysticercosis. Neurology 1994;44:1706-1709.
4. Spina-França, A, Livramento JA, Machado LR. Cysticercosis of the central nervous system and cerebrospinal fluid: immunodiagnosis of 1573 patients in 63 years. Arq Neuropsiquiatr 1993;51:16-20.
5. Monteiro L, Nunes B, Mendonça D, Lopes J. Spectrum of epilepsy in neurocysticercosis: a long-term follow-up of 143 patients. Acta Neurol Scand 1995;92:33-40.
6. Carpio A, Santillán F, León P. Aspectos clinicos de la cisticercosis. Rev Inst Cienc Salud (Ecuador) 1990;5:1-40.
7. Palacio LG, Jiménez I, Garcia HH, et al. Neurocysticercosis in persons with epilepsy in Medellín, Colombia, Epilepsia 1998;39:1334-1339.
8. Garcia HH, Gilman R, Martinéz M, et al. Cysticercosis as a major cause of epilepsy in Peru. Lancet 1993;341:197-200.
9. Medina MT, Rosas E, Rubio-Donnadieu F, Sotelo J. Neurocysticercosis as the main cause of late-onset epilepsy in Mexico. Arch Intern Med 1990;150:323-325.
10. Sotelo J, Escobedo F, Rodriguez-Carbajal J, Rubio-Donnadieu F. Therapy of parenchymal brain cysticercosis with praziquantel. N Engl J Med. 1984;310:1001-1007.
11. Shawhney IMS, Lekhra, OP, Shashi JS, et al. Evaluation of epilepsy management in a developing country: a prospective study of 407 patients. Acta Neurol Scand 1996;94:19-23.
12. Comission on Classification and Terminology of the International League Against Epilepsy. Proposal for revised classification of epilepsies and epileptic seizures. Epilepsia 1989;30:389-399.
13. Takayanagui OM, Jardim E. Therapy for neurocysticercosis: comparison between albendazole and praziquantel. Arch Neurol 1992;49:290-294.
14. Carpio A, Santillán F, León P. et al. Is the course of neurocysticercosis modified by treatment with antibelminthic agents? Arch Intern Med 1995;155:1982-1988.
15. Kramer LD. Medical Treatment of cysticercosis-ineffective. Arch Neurol 1995;52:101-102.
16. Hachinski V. Medical treatment of cysticercosis. Arch Neurol 1995;52:104.
17. Krammer LD, Locke GE, Byrd SE, Daryabagi J. Cerebral cysticercosis: documentation of natural history with CT. Radiology 1989;171:459-462.
18. Cukiert A, Pugli P, Scapolan HB, et al. Congruence of the topography of intracranial calcifications and epileptic foci. Arq Neuropsiquiatr 1994;52:289-294.
19. Escobedo F, Penagos P, Rodríguez J, Sotelo J, Albendazole therapy for neurocysticercosis. Arch Intern Med 1987;147:738-741.
20. Murthy JMK, Reddy YVS. Prognosis of epilepsy associated with single CT enhancing lesion: a long term follow up study. J Neurol Sci 1998;159:151-155.
21. Bittencourt PRM, Adamolekum B, Bharucha N, et al. Epilepsy in the tropics: II. Clinical presentations, pathophysiology, immunologic diagnosis, economics and therapy. Epilepsia 1996;37:1121-1127.
22. Del Brutto OH, Santibañez R, Noboa CA, et al. Epilepsy due to neurocysticercosis: analysis of 203 patients. Neurology 1992;42:389-392.
23. Narata AP, Arruda WO, Uemura E, et al. Neurocisticercose: diagnósfico tomográfico em pacientes neurológicos. Arq Neuropsiquiatr 1998;56(2):245-249.
24. Minguetti G, Ferreira M. Computed tomography in neurocysticercosis. J Neurol Neurossurg Psychiatry 1983;46:926-942.
25. Chequer RS, Vieira VL. Neurocisticercose no Estado do Espírito Santo. Arq Neuropsiquiatr 1990;48:431-440.
26. Daras M, Tuchman AJ, Strobos RJ. Computed tomography in adult onset epileptic seizures in a city hospital population Epilepsia 1987;28:519-522.
27. Singh G. Neurocysticercosis in South-Central America and the Indian Subcontinent: a comparative evaluation. Arq Neuropsiquiatr 1997;55:349-356.
28. Sethi PK, Kuar BR, Madan VS, et al. Appearing and disappearing CT scan abnormalities and seizures. J Neurol Neurossurg Psychiatry 1985;48:866-869.
29. Chandy MJ, Rajshekhar V, Ghosh S, et al. Single small enhancing CT lesions in Indian patients with epilepsy: clinical, radiological and pathological considerations. J Neurol Neurossurg Psychiatry 1991;54:702-705.
30. Rajsheklar V. Albendazole theraphy for persistent solitary cysticercus granuloma in patient with seizures. Neurology 1993;43:1238-1240.
31. Vazquez V, Sotelo J. The course of seizures after treatment for cerebral cysticercosis. N Engl J Med 1992;327:696-701.
32. Alarcón F, Escalante L, Dueñas G, et al. Neurocysticercosis: short course of treatment with albendazole. Arch Neurol 1989;46:1231-1236.